Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses

Group B Streptococcus (GBS) is associated with invasive disease in utero and stillbirth. We estimated that 1% of all stillbirths in developed countries and 4% in Africa were associated with GBS.

[1]  S. Madhi,et al.  Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Madhi,et al.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S. Madhi,et al.  Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Madhi,et al.  Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Madhi,et al.  Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  S. Madhi,et al.  Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Madhi,et al.  Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Madhi,et al.  Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Madhi,et al.  Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Madhi,et al.  Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Q. Bassat,et al.  Validity of a minimally invasive autopsy for cause of death determination in stillborn babies and neonates in Mozambique: An observational study , 2017, PLoS medicine.

[12]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[13]  S. Madhi,et al.  Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[14]  S. Schrag,et al.  Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya , 2016, Nature Microbiology.

[15]  David Osrin,et al.  Stillbirths: rates, risk factors, and acceleration towards 2030 , 2016, The Lancet.

[16]  C. Mathers,et al.  National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis. , 2016, The Lancet. Global health.

[17]  Z. Dangor,et al.  Maternal group B Streptococcus‐related stillbirth: a systematic review , 2015, BJOG : an international journal of obstetrics and gynaecology.

[18]  Jamie Perin,et al.  Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis , 2015, The Lancet.

[19]  V. Balaji,et al.  Group B Streptococcal Infection in a Tertiary Hospital in India—1998–2010 , 2014, The Pediatric infectious disease journal.

[20]  Colin Mathers,et al.  Every Newborn: progress, priorities, and potential beyond survival , 2014, The Lancet.

[21]  F. Facchinetti,et al.  Fetal bacterial infections in antepartum stillbirth: a case series. , 2013, Early human development.

[22]  S. Madhi,et al.  Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. , 2013, Vaccine.

[23]  S. Schrag,et al.  Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis , 2012, The Lancet.

[24]  U. Reddy,et al.  Infection-related stillbirths , 2010, The Lancet.

[25]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[26]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[27]  T. Colbourn,et al.  An overview of the natural history of early onset group B streptococcal disease in the UK. , 2007, Early human development.

[28]  R. Romero,et al.  Maternal and fetal inflammatory responses in unexplained fetal death , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[29]  L. Nyström,et al.  Intrauterine infection may be a major cause of stillbirth in Sweden , 2001, Acta obstetricia et gynecologica Scandinavica.

[30]  S. Bergström,et al.  A case‐referent study on fetal bacteremia and late fetal death of unknown etiology in Lithuania , 2000, Acta obstetricia et gynecologica Scandinavica.

[31]  S. Bergström,et al.  A case control study of chorioamniotic infection and histological chorioamnionitis in stillbirth , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[32]  L. Nyström,et al.  Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[33]  P. Thomassen,et al.  Sixty‐six cases of intrauterine fetal death , 1995, Acta obstetricia et gynecologica Scandinavica.

[34]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[35]  K. Christensen.  Infection as a Predominant Cause of Perinatal Mortality , 1982, Obstetrics and gynecology.

[36]  Christensen Kk.  Infection as a predominant cause of perinatal mortality , 1982 .

[37]  G. Holmberg,et al.  Intrauterine Death Due to Infection with Group B Streptococci , 1978, Acta obstetricia et gynecologica Scandinavica.

[38]  George W. Dameron,et al.  Beta hemolytic streptococcus group B associated with problems of the perinatal period. , 1961, American journal of obstetrics and gynecology.

[39]  N. Embleton.  Fetal and neonatal death from maternally acquired infection. , 2001, Paediatric and perinatal epidemiology.